Systematic review finds that combining radiotherapy and immunotherapy improves survival in advanced hepatocellular carcinoma, suggesting further research is needed to enhance treatment strategies.
RT combined with ICIs shows promising improvements in survival and tumor response compared to ICI alone in advanced HCC, albeit with increased toxicity. Large randomized trials are needed to confirm efficacy, optimize RT regimens, and identify patients most likely to benefit.
No takes yet. Share an insight, caveat, or question.
Saqib et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: